The pathogenesis of insulin resistance: integrating signaling pathways and substrate flux
Open accessThe DOI matches its Crossref record; 131 of the 131 references it cites were found in a registry or an index.
Abstract
Insulin resistance arises when the nutrient storage pathways evolved to maximize efficient energy utilization are exposed to chronic energy surplus. Ectopic lipid accumulation in liver and skeletal muscle triggers pathways that impair insulin signaling, leading to reduced muscle glucose uptake and decreased hepatic glycogen synthesis. Muscle insulin resistance, due to ectopic lipid, precedes liver insulin resistance and diverts ingested glucose to the liver, resulting in increased hepatic de novo lipogenesis and hyperlipidemia. Subsequent macrophage infiltration into white adipose tissue (WAT) leads to increased lipolysis, which further increases hepatic triglyceride synthesis and hyperlipidemia due to increased fatty acid esterification. Macrophage-induced WAT lipolysis also stimulates hepatic gluconeogenesis, promoting fasting and postprandial hyperglycemia through increased fatty acid delivery to the liver, which results in increased hepatic acetyl-CoA content, a potent activator of pyruvate carboxylase, and increased glycerol conversion to glucose. These substrate-regulated processes are mostly independent of insulin signaling in the liver but are dependent on insulin signaling in WAT, which becomes defective with inflammation. Therapies that decrease ectopic lipid storage and diminish macrophage-induced WAT lipolysis will reverse the root causes of type 2 diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Supporting this perspective, monosaccharides have been shown to activate ChREBP and other key lipogenic transcription factors—including SREBP1c, LXR, and PPARγ—via insulin-independent mechanisms [34,70,83,86,99].”
From Hepatic Insulin Resistance and Steatosis in Metabolic Dysfunction-Associated Steatotic Liver Disease: New Insights into Mechanisms and Clinical Implications (2025) · cites this paper as [99]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In both animal models and human patients, obesity‐induced hyperlipidaemia and lipotoxicity‐induced inflammation is thought to be one of the drivers for SO.[ 63 ]”
From Pathogenesis of sarcopenia and the relationship with fat mass: descriptive review (2022) · cites this paper as [63]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“In lipid infusion experiments, DAG content in the muscle increases, and consequently PKCθ is activated, resulting in limited phosphorylation of IRS-1 and glucose uptake through GLUT4 [9].”
From Sarcopenic obesity, insulin resistance, and their implications in cardiovascular and metabolic consequences (2020) · cites this paper as [9]
In the citing paper
“Insulin resistance is the core mechanism of sarcopenic obesity and is also associated with variable cardiometabolic diseases such as cardiovascular disease, type 2 diabetes mellitus, and non-alcoholic fatty liver disease.”
From Sarcopenic obesity, insulin resistance, and their implications in cardiovascular and metabolic consequences (2020) · cites this paper as [9]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Obesity is associated with macrophage accumulation in adipose tissue
Weisberg, S. P., McCann, D., Desai, M., Rosenbaum, M., Leibel, R. L., & Ferrante, A. W. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319246 · Cited by 10,041 · cited 1×
“Activated adipose tissue macrophages (ATMs) are recruited via chemokine signaling (96, 97) and release cytokines that promote lipolysis.”
BackgroundThe metabolic phenotype in obesity: Fat mass, body fat distribution, and adipose tissue function
Goossens, G. H. (2017) · Obesity Facts · doi:10.1159/000471488 · Cited by 8,481
Xu, H., Barnes, G. T., Yang, Q., Tan, G., Yang, D., Chou, C. J., Sole, J., Nichols, A., Ross, J. S., Tartaglia, L. A., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319451 · Cited by 6,760 · cited 1×
“Activated adipose tissue macrophages (ATMs) are recruited via chemokine signaling (96, 97) and release cytokines that promote lipolysis.”
BackgroundLippa, N. C., & Sanderson, S. C. (2013) · Human Heredity · doi:10.1159/000353712 · Cited by 6,078
Adipose Tissue as an Endocrine Organ
Kershaw, E. E., & Flier, J. S. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0395 · Cited by 5,522
Randle, P. J., Garland, P. B., Hales, C. N., & Newsholme, E. A. (1963) · The Lancet · doi:10.1016/s0140-6736(63)91500-9 · Cited by 5,093 · cited 2×
“Over a half century ago, Randle and colleagues concluded that muscle insulin resistance associated with obesity could be attributed to increased fatty acid oxidation that limits insulin-stimulated glucose utilization (43).”
BackgroundGenetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease
Romeo, S., Kozlitina, J., Xing, C., Pertsemlidis, A., Cox, D., Pennacchio, L. A., Boerwinkle, E., Cohen, J. C., & Hobbs, H. H. (2008) · Nature Genetics · doi:10.1038/ng.257 · Cited by 3,416 · cited 1×
“A common single nucleotide polymorphism (rs738409, I48M) in the lipid droplet protein patatin-like phospholipase domaincontaining protein 3 (PNPLA3, also called adiponutrin) has been associated with increased hepatic steatosis but not insulin resistance (74).”
BackgroundKim, H. J., Park, S. Y., Choi, Y. J., Han, S. J., Lee, K. W., & Kim, D. J. (2013) · Hormone Research in Paediatrics · doi:10.1159/000348848 · Cited by 3,048
Defining the role of mTOR in cancer
Guertin, D. A., & Sabatini, D. M. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.05.008 · Cited by 2,833 · cited 1×
“Insulin activates the insulin receptor tyrosine kinase (IRTK), with subsequent activation of kinases including 3-phosphoinositide-dependent kinase-1 (PDK1) and mTORC2 (6), which converge on Akt phosphorylation (6–8).”
BackgroundAlessi, D. R., James, S. R., Downes, C. P., Holmes, A. B., Gaffney, P. R. J., Reese, C. B., & Cohen, P. (1997) · Current Biology · doi:10.1016/s0960-9822(06)00122-9 · Cited by 2,826
Research works printed but not linked: 6
- 10.1210/jcem.87.8.8761 · doi:10.1210/jcem.87.8.8761 · Paper page
- Kersten, 2014, Physiological regulation of lipoprotein lipase, Biochim Biophys Acta, 1841, 919, 10.1016/j.bbalip.2014.03.013 · DOI · Paper page
- 10.1172/JCI10294 · DOI · Paper page
- 10.1172/JCI15001 · doi:10.1172/jci15001 · Paper page
- 10.1172/JCI19246 · doi:10.1172/jci19246 · Paper page
- 10.1172/JCI19451 · doi:10.1172/jci19451 · Paper page
Cited by
Items 301–400 of 998
Low-carbohydrate diets for the treatment of obesity and type 2 diabetes
Hall, K. D., & Chung, S. T. (2018) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0000000000000470 · Cited by 46
GLUT4 Storage Vesicles: Specialized Organelles for Regulated Trafficking.
Li, D. T., Habtemichael, E. N., Julca-Zevallos, O., Sales, C., Westergaard, X. O., DeVries, S. G., Ruiz, D. M., Sayal, B. S., & Bogan, J. S. (2019) · PubMed Central · Cited by 56
Haye, A., Ansari, M. A., Rahman, S. O., Shamsi, Y., Ahmed, D., & Sharma, M. (2020) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2020.173376 · Cited by 49
Emerging Roles of Calcium Signaling in the Development of Non-Alcoholic Fatty Liver Disease
Chen, C.-C., Hsu, L., Chen, K., Chiu, K., Chen, C., & Huang, K. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms23010256 · Cited by 58
“This action is highly regulated by insulin [4].”
BackgroundAmino acid profiles of young adults differ by sex, body mass index and insulin resistance
Guevara‐Cruz, M., Morales, J. M. V., Méndez-García, A. L., López‐Barradas, A. M., Granados‐Portillo, O., Ordáz‐Nava, G., Rocha‐Viggiano, A. K., Gutierrez-Leyte, C. A., Medina-Cerda, E., Rosado, J. L., et al. (2018) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2018.01.001 · Cited by 54
Gao, J., Song, J., Du, ., & Mao, X. (2018) · Nutrients · doi:10.3390/nu10020242 · Cited by 46
Relaxin as a Therapeutic Target for the Cardiovascular Complications of Diabetes
Ng, H. H., Leo, C. H., Parry, L. J., & Ritchie, R. H. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00501 · Cited by 47
“Inhibition of both glucose metabolism and fatty acid uptake (Randle et al., 1963), and muscle glucose uptake via PKCζ activation (Samuel and Shulman, 2016) all contribute to the pathophysiology of diabetes.”
BackgroundHabtemichael, E. N., Li, D. T., Alcázar-Román, A., Westergaard, X. O., Li, M., Petersen, M. C., Li, H., DeVries, S. G., Li, E., Julca-Zevallos, O., et al. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.003021 · Cited by 44
“It has been argued that the Akt pathway is sufficient to mediate insulin action, and this pathway has been the focus of substantial work on insulin resistance (41, 42).”
BackgroundGamede, M. W., Mabuza, L. P., Ngubane, P. S., & Khathi, A. (2019) · Molecules · doi:10.3390/molecules24020340 · Cited by 51
“the increase in circulating triglycerides, very low-density lipoprotein-cholesterol, with a decrease in high density lipoprotein-cholesterol [38].”
BackgroundResveratrol ameliorates inflammatory and oxidative stress in type 2 diabetic Goto-Kakizaki rats
Szkudelska, K., Okulicz, M., Hertig, I., & Szkudelski, T. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110026 · Cited by 48
Song, L., Liu, J., Shi, T., Zhang, Y., Zhong, X., Cao, X., & Yang, J. (2020) · The FASEB Journal · doi:10.1096/fj.202001639r · Cited by 46
Nascè, A., Gariani, K., Jornayvaz, F. R., & Szántó, I. (2022) · Antioxidants · doi:10.3390/antiox11061131 · Cited by 56
“In contrast, incubation in the presence of polyunsaturated fatty acids (PUFAs) elicits the secretion of the anti-inflammatory cytokine IL-10 [149].”
BackgroundParticipation of Magnesium in the Secretion and Signaling Pathways of Insulin: an Updated Review
Melo, S. R. D. S., dos Santos, L. R., Soares, T. D. C., Cardoso, B. E. P., Dias, T. M. D. S., Morais, J. B. S., Sousa, M. D. P., de Sousa, T. G. V., da Silva, N. C., da Silva, L. D., et al. (2022) · Biological Trace Element Research · doi:10.1007/s12011-021-02966-x · Cited by 60
“It instead favors the manifestation of insulin resistance, characterized by hyperglycemia and hyperinsulinemia [18, 19].”
BackgroundPan, Y., Li, J., Lin, P., Wan, L., Qu, Y., Cao, L., & Wang, L. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1348410 · Cited by 54
Sima, C., Montero, E., Nguyen, D., Freire, M., Norris, P. C., Serhan, C. N., & Dyke, T. E. V. (2017) · Scientific Reports · doi:10.1038/s41598-017-13185-7 · Cited by 48
Lü, Y., Wang, E., Chen, Y., Zhou, B., Zhao, J., Xiang, L., Qian, Y., Jiang, J., Zhao, L., Xiong, X., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci134485 · Cited by 46
“In addition, some animal studies have shown the metabolic benefits of 11β-HSD1 inhibitors, although careful consideration and more clinical data are still required in T2DM patients (49, 50).”
BackgroundInfluentialAtherosclerosis and Insulin Resistance: Is There a Link Between Them?
Brie, A. D., Christodorescu, R., Popescu, R., Adam, O., Tîrziu, A., & Brie, D. M. (2025) · Biomedicines · doi:10.3390/biomedicines13061291 · Cited by 58
Role of E3 ubiquitin ligases in insulin resistance
Yang, X., Xiang, D., & Yang, Y. (2016) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12677 · Cited by 43
“Insulin resistance is a fundamental pathogenic factor shared by these diseases [2].”
BackgroundGao, N., Yao, X., Jiang, L., Yang, L., Qiu, T., Wang, Z., Pei, P., Yang, G., Liu, X., & Sun, X. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.27318 · Cited by 46
“IR is the basic pathogenesis of T2D and is also closely related to chronic metabolic diseases, such as hypertension, fatty liver, atherosclerosis, and obesity (Samuel & Shulman, 2016).”
BackgroundPan, K., Wu, X., Xu, M., Feng, J., Xu, H., Gan, Y., Wang, C., Deng, Z., Liu, X., Fu, W., et al. (2021) · Eating and Weight Disorders - Studies on Anorexia Bulimia and Obesity · doi:10.1007/s40519-021-01238-w · Cited by 47
Astaxanthin as a metabolic regulator of glucose and lipid homeostasis
Medoro, A., Intrieri, M., Passarella, D., Willcox, D. C., Davinelli, S., & Scapagnini, G. (2023) · Journal of Functional Foods · doi:10.1016/j.jff.2023.105937 · Cited by 46
Epigenetics and Type 2 Diabetes Risk
Dhawan, S., & Natarajan, R. D. (2019) · Current Diabetes Reports · doi:10.1007/s11892-019-1168-8 · Cited by 52
Inflammation and metabolism: the role of adiposity in sarcopenic obesity
Lynch, G. M., Murphy, C. H., Castro, E. D. M., & Roche, H. M. (2020) · Proceedings of the Nutrition Society · doi:10.1017/s0029665120007119 · Cited by 41
“IR is defined as sub-optimal insulinstimulated glucose uptake into metabolic tissues, including skeletal muscle and adipose tissue((39,40)).”
BackgroundEffect of low carbohydrate diets on insulin resistance and the metabolic syndrome
Foley, P. J. (2021) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000659 · Cited by 47
“In order to ensure homeostasis, more insulin is then secreted which results in a combined state of hyperglycaemia and hyperinsulinaemia in both fasted and postprandial states [10].”
BackgroundThe Therapeutic Effects of Magnesium in Insulin Secretion and Insulin Resistance
Dastgerdi, A. H., Rad, M. G., & Soltani, N. (2022) · Advanced Biomedical Research · doi:10.4103/abr.abr_366_21 · Cited by 53
“[10,22] Guerrero‑Romero has stated that the intake of supplements containing 50 mL MgCl2 for 16 weeks remarkably improved homeostatic model assessment for IR (HOMA‑IR), fasting blood sugar (FBS), and hemoglobin A1c (HbA1c) in individuals with T2D.”
BackgroundInfluentialJayaraman, S., Krishnamoorthy, K., Prasad, M., Veeraraghavan, V. P., Krishnamoorthy, R., Alshuniaber, M. A., Gatasheh, M. K., Elrobh, M. S., & Gunassekaran (2023) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2023.124917 · Cited by 54
Chen, X., Liu, D., He, W., Hu, H., & Wang, W. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-04402-1 · Cited by 46
“…leads to transport of high free fatty acids to the liver leading to high glucose output in the liver, that is, free fatty acids can increase gluconeogenesis in the liver [33], and high levels of triglycerides in the liver and muscle can interfere with glucose metabolism in each target organ.”
BackgroundCardiovascular Risk in Patients with Prehypertension and the Metabolic Syndrome
Kachur, S. M., Morera, R., Schutter, A. D., & Lavie, C. J. (2018) · Current Hypertension Reports · doi:10.1007/s11906-018-0801-2 · Cited by 47
Sbraccia, P., D’Adamo, M., & Guglielmi, V. (2021) · Eating and Weight Disorders - Studies on Anorexia Bulimia and Obesity · doi:10.1007/s40519-021-01109-4 · Cited by 50
Sphingosine 1-phosphate metabolism and insulin signaling
Wigger, D., Schumacher, F., Schneider‐Schaulies, S., & Kleuser, B. (2021) · Cellular Signalling · doi:10.1016/j.cellsig.2021.109959 · Cited by 45
Pathology of metabolically-related dyslipidemia
Su, X., Chen, X., & Wang, B. (2021) · Clinica Chimica Acta · doi:10.1016/j.cca.2021.06.029 · Cited by 53
Li, D., Jia, L., Wu, X.-L., & Cheng, M. Y. (2025) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s508365 · Cited by 69
“These findings are consistent with the primary analysis and further support the relationship between BMI and HbA1c (Figure 3).”
Distinct Metabolic Profiles are Associated with Colorectal Adenomas and Serrated Polyps
Isakov, N. F., Zelber‐Sagi, S., Webb, M., Halpern, Z., Shibolet, O., & Kariv, R. (2017) · Obesity · doi:10.1002/oby.22001 · Cited by 45
“The association between colorectal neoplasia and the HbA1c% has been shown in previous studies of subjects with diabetes (33), but there have been studies among people without diabetes that reported a lack of association (34).”
BackgroundInfluentialKors, L., Rampanelli, E., Stokman, G., Butter, L. M., Held, N. M., Claessen, N., Larsen, P. W. B., Verheij, J., Zuurbier, C. J., Liebisch, G., et al. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2018.03.003 · Cited by 51
Function of Pro-Resolving Lipid Mediator Resolvin E1 in Type 2 Diabetes
Sima, C., Paster, B. J., & Dyke, T. E. V. (2018) · Critical Reviews in Immunology · doi:10.1615/critrevimmunol.2018026750 · Cited by 45
Regulation of Glucose Production in the Pathogenesis of Type 2 Diabetes
Sargsyan, A., & Herman, M. A. (2019) · Current Diabetes Reports · doi:10.1007/s11892-019-1195-5 · Cited by 47
The emergence of protein arginine methyltransferases in skeletal muscle and metabolic disease
vanLieshout, T. L., & Ljubicic, V. (2019) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00251.2019 · Cited by 40
Fahlbusch, P., Knebel, B., Hörbelt, T., Barbosa, D. M., Nikolic, A., Jacob, S., Al‐Hasani, H., de Velde, F. V., Nieuwenhove, Y. V., Müller‐Wieland, D., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21114144 · Cited by 40
Kim, A., Koo, J. H., Jin, X., Kim, W., Park, S., Park, S., Rhee, E. P., Choi, C. S., & Kim, S. G. (2021) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.12777 · Cited by 44
Prasad, M., Gatasheh, M. K., Alshuniaber, M. A., Krishnamoorthy, R., Rajagopal, P., Krishnamoorthy, K., Vijayalakshmi, P., Veeraraghavan, V. P., & Jayaraman, S. (2022) · Antioxidants · doi:10.3390/antiox11122436 · Cited by 42
Curcumin improves insulin sensitivity in high-fat diet-fed mice through gut microbiota
Zhong, Y., Xiao, Y., Gao, J., Zheng, Z., Zhang, Z., Yao, L., & Li, D. (2022) · Nutrition & Metabolism · doi:10.1186/s12986-022-00712-1 · Cited by 45
“mice Insulin resistance upregulates the expression of genes involved in the hepatic gluconeogenesis and de novo lipogenesis (DNL), which leads to the abnormal enhancement of the hepatic gluconeogenesis and DNL, thereby inducing hyperglycemia and hepatosteatosis [4, 21, 22].”
BackgroundDarweesh, M. F., Mohammadi, S., Rahmati, M., Al-Hamadani, M., & Al‐Harrasi, A. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1578202 · Cited by 54
Zhu, M. J., Kang, Y., Xue, Y., Liang, X., García, M. P. G., Rodgers, D. B., Kagel, D. R., & Du, . (2017) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2017.10.012 · Cited by 39
The improvements of functional ingredients from marine foods in lipid metabolism
Wang, T., Xue, C., Zhang, T., & Wang, Y. (2018) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2018.09.004 · Cited by 39
Štěpánek, L., Horáková, D., Štěpánek, L., Janout, V., Janoutová, J., Bouchalová, K., & Martiník, K. (2020) · Endokrynologia Polska · doi:10.5603/ep.a2020.0066 · Cited by 45
“IR represents a key pathogenetic mechanism of cardiometabolic diseases, and its prevention is crucial in the current dominance of cardiometabolic diseases in overall mortality [6, 7].”
BackgroundMoreno‐Vedia, J., Girona, J., Ibarretxe, D., Masana, L., & Rodríguez‐Calvo, R. (2022) · Biomedicines · doi:10.3390/biomedicines10010197 · Cited by 52
“Both mechanisms (increased liver fatty acid uptake and de novo lipogenesis) lead to liver triglyceride deposition, exceeding the mechanisms for fat removal, such as very low-density lipoprotein (VLDL) secretion and mitochondrial fatty acid β-oxidation [37,38], further promoting liver triglyceride [40,41] and other lip…”
BackgroundRole of epigenomic mechanisms in the onset and management of insulin resistance
Izquierdo, A. G., & Crujeiras, A. B. (2019) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-019-09485-0 · Cited by 41
Mechanistic insight into allosteric activation of human pyruvate carboxylase by acetyl-CoA
Chai, P., Lan, P., Li, S., Yao, D., Chang, C., Mi, C., Shen, Y., Ge, S., Wu, J., Lei, M., et al. (2022) · Molecular Cell · doi:10.1016/j.molcel.2022.09.033 · Cited by 39
Insights into genetic variants associated with NASH-fibrosis from metabolite profiling
Mann, J. P., Pietzner, M., Wittemans, L. B., Rolfe, E. D. L., Kerrison, N. D., Imamura, F., Forouhi, N. G., Fauman, E., Allison, M. E., Griffin, J. L., et al. (2020) · Human Molecular Genetics · doi:10.1093/hmg/ddaa162 · Cited by 38
“Both of these variants are strongly associated with higher liver fat and steatosis itself may affect systemic insulin resistance (66,67).”
BackgroundManco, M., Guerrera, S., Ravà, L., Atti, M. L. C. D., Vara, S. D., Valeri, G., & Vicari, S. (2021) · Translational Psychiatry · doi:10.1038/s41398-021-01345-3 · Cited by 45
Xia, Q., Wu, F., Wu, W., Dong, H., Huang, Z., Xu, L., Lu, F., & Gong, J. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.112955 · Cited by 43
Liu, Y., Huang, W., Dai, K., Liu, N., Wang, J., Lü, X., Ma, J., Zhang, M., Xu, M., Xu, L., et al. (2022) · Journal of Oral Microbiology · doi:10.1080/20002297.2022.2088936 · Cited by 39
“Besides, the accumulation of TG has been implicated in the pathogenesis of insulin resistance and could act as a metabolic marker in the liver [66].”
BackgroundLópez-Vicario, C., Rius, B., Alcaraz-Quiles, J., González-Périz, A., Martínez-Puchol, A. I., Casulleras, M., Duran-Güell, M., Ibarzabal, A., Corcelles, R., Laguna-Fernández, A., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-15951-z · Cited by 37
Koh, E. H., Chen, Y., Bader, D. A., Hamilton, M. P., He, B., York, B., Kajimura, S., McGuire, S. E., & Hartig, S. M. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.749408 · Cited by 37
“Visceral WAT expansion and ectopic lipid accumulation in the liver, heart, and skeletal muscle are significant risk factors for insulin resistance, type 2 diabetes mellitus (T2DM), and cardiovascular disease (1).”
Backgroundvan Zutphen, T., Stroeve, J. H. M., Yang, J., Bloks, V. W., Jurdzinski, A., Roelofsen, H., Huijkman, N., van Dijk, T. H., Vonk, R. J., van Deursen, J., et al. (2019) · Journal of Lipid Research · doi:10.1194/jlr.m094508 · Cited by 40
“Ectopic lipid accumulation, accompanied by increased concentrations of intermediates of lipid metabolism, such as diacylglycerols and ceramides, is one of the drivers of insulin resistance (51).”
BackgroundLiu, E.-Q., Weng, Y., Zhou, A., & Zeng, C. (2020) · BioMed Research International · doi:10.1155/2020/2947067 · Cited by 40
“, skeletal muscle, fat, and liver) do not respond appropriately to insulin stimulation [5].”
BackgroundBashkin, A., Ghanim, M., Abu‐Farich, B., Rayan, M., Miari, R., Srouji, S., Rayan, A., & Falah, M. (2021) · Molecules · doi:10.3390/molecules26020317 · Cited by 41
“DM is a metabolic disorder affecting hundreds of millions of people throughout the globe [8]; it is caused either by an insulin deficiency (type 1 diabetes) or by insulin resistance (type 2 diabetes) [9,10].”
BackgroundSuicidal Erythrocyte Death in Metabolic Syndrome
Restivo, I., Attanzio, A., Tesoriere, L., & Allegra, M. (2021) · Antioxidants · doi:10.3390/antiox10020154 · Cited by 42
Kalyesubula, M., Mopuri, R., Asiku, J., Rosov, A., Yosefi, S., Edery, N., Bocobza, S. E., Moallem, U., & Dvir, H. (2021) · Disease Models & Mechanisms · doi:10.1242/dmm.048355 · Cited by 43
“Since thiamine did not affect plasma insulin, which together with glucose as a substrate for glycogen, is known to upregulate hepatic glycogen levels (Samuel and Shulman, 2016), the increase in hepatic glycogen by thiamine might indicate improved hepatic sensitivity to insulin.”
Insulin resistance in glomerular podocytes: Potential mechanisms of induction
Rogacka, D. (2021) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2021.109005 · Cited by 40
Phospholipases D1 and D2 Suppress Appetite and Protect against Overweight
Viera, J. T., El‐Merahbi, R., Nieswandt, B., Stegner, D., & Sumara, G. (2016) · PLoS ONE · doi:10.1371/journal.pone.0157607 · Cited by 37
“This elevation of FFA promotes peripheral insulin resistance [27].”
BackgroundInfluentialAbbasi, A., Bazzaz, S., da Cruz, A. G., Khorshidian, N., Saadat, Y. R., Sabahi, S., Ozma, M. A., Lahouty, M., Aslani, R., & Mortazavian, A. M. (2023) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-023-10118-x · Cited by 40
“Increased insulin signal activation was shown to be the cause of decreased liver and muscle fatty acid production and transportation following treatment with A. muciniphila [29].”
Brain–body communication in metabolic control
Furlan, A., & Petrus, P. (2023) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2023.08.014 · Cited by 37
“Conversely, insulin, secreted from β-cells of the pancreas, shifts hepatic metabolism from gluconeogenesis and glycogen breakdown to glycolysis, de novo lipogenesis (DNL), and glycogen synthesis [11].”
BackgroundMechanisms of Insulin Resistance in Patients with Obesity
Arneth, B. (2024) · Endocrines · doi:10.3390/endocrines5020011 · Cited by 45
“Recent investigations have shown that the brain usually processes information related to different adiposity signals, such as leptin and insulin [26,27].”
Xiao, N., Ding, Y., Cui, B., Li, R., Qu, X.-R., Zhou, H., Au, K.-H., Fan, X.-D., Xie, J.-C., Huang, Y., et al. (2024) · The Innovation Medicine · doi:10.59717/j.xinn-med.2024.100090 · Cited by 43
Research status of triglyceride glucose-body mass index (TyG-BMI index)
Song, K., Xu, Y., Wu, S., Zhang, X., Wang, Y., & Pan, S. (2025) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2025.1597112 · Cited by 44
“In IR (22), the phosphatidylinositol-3-kinase PI3K pathway results in a decrease in NO production, while the mitogen-activated protein kinase (MAPK) pathway is triggered, which causes vasoconstriction (23), causing the development of HTN. HTN has become the most important risk factor for the…”
E2F1 promotes hepatic gluconeogenesis and contributes to hyperglycemia during diabetes
Giralt, A., Denechaud, P., López‐Mejía, I. C., Delacuisine, B., Blanchet, É., Bonner, C., Pattou, F. N., Annicotte, J., & Fajas, L. (2018) · Molecular Metabolism · doi:10.1016/j.molmet.2018.02.011 · Cited by 42
“Although some explanations have been proposed, this phenomenon is not yet fully understood [4,5].”
BackgroundEgami, R., Kokaji, T., Hatano, A., Yugi, K., Eto, M., Morita, K., Ohno, S., Fujii, M., Hironaka, K., Uematsu, S., et al. (2021) · iScience · doi:10.1016/j.isci.2021.102217 · Cited by 37
Sarmiento-Ortega, V. E., Moroni-González, D., Díaz, A., Brambila, E., & Treviño, S. (2021) · Biological Trace Element Research · doi:10.1007/s12011-021-03027-z · Cited by 40
“Cadmium, directly and indirectly, causes insulin resistance via the insulin receptor due to of the hyperphosphorylation of tyrosine residues [46].”
BackgroundUpdated Understanding of the Crosstalk Between Glucose/Insulin and Cholesterol Metabolism
Xiao, X., Luo, Y., & Peng, D. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.879355 · Cited by 70
Adipose Tissue Insulin Resistance: A Key Driver of Metabolic Syndrome Pathogenesis
Rabiee, A., Hossain, M. A., & Poojari, A. (2025) · Biomedicines · doi:10.3390/biomedicines13102376 · Cited by 63
“It addresses severe conditions like type 2 diabetes and cardiovascular disease [6].”
Impaired Vascular Redox Signaling in the Vascular Complications of Obesity and Diabetes Mellitus
Akoumianakis, I., & Antoniades, C. A. (2017) · Antioxidants and Redox Signaling · doi:10.1089/ars.2017.7421 · Cited by 41
Reversing the tide — diagnosis and prevention of T2DM in populations of African descent
Utumatwishima, J. N., Chung, S. T., Bentley, A. R., Udahogora, M., & Sumner, A. E. (2017) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2017.127 · Cited by 38
Dietary protein dilution limits dyslipidemia in obesity through FGF21-driven fatty acid clearance
Maida, A., Zota, A., Vegiopoulos, A., Appak‐Baskoy, S., Augustin, H. G., Heikenwälder, M. F., Herzig, S., & Rose, A. J. (2018) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2018.03.027 · Cited by 35
Oxytocin and Vasopressin Systems in Obesity and Metabolic Health: Mechanisms and Perspectives
Ding, C., & Magkos, F. (2019) · Current Obesity Reports · doi:10.1007/s13679-019-00355-z · Cited by 40
González‐Rodríguez, M., Pazos-Couselo, M., López, J. M. G., Rodríguez‐Segade, S., Rodríguez, J., Túñez-Bastida, C., & Gudé, F. (2019) · Nutrition & Metabolism · doi:10.1186/s12986-019-0368-1 · Cited by 43
“Besides, lipid accumulation in skeletal muscle impairs insulin signaling and then contributes to the flattened blood glucose response [31].”
BackgroundMutt, S. J., Raza, G. S., Mäkinen, M. J., Keinanen-Kiukaanniemi, S. M., Järvelin, M., & Herzig, K. (2019) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201900728 · Cited by 38
Keddar, M., Muylle, T., Carrie, E., Tréfois, P., Nachit, M., Crott, R., Christiaens, C., Bammens, B., Jadoul, M. Y., Goffin, E. J., et al. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.00130 · Cited by 38
“The mechanisms by which ectopic fat accumulation promotes insulin resistance and CVD have only been partially elucidated (Shulman, 2014; Samuel and Shulman, 2016; Neeland et al., 2018; Petersen and Shulman, 2018).”
BackgroundSekiya, M., Kainoh, K., Sugasawa, T., Yoshino, R., Hirokawa, T., Tokiwa, H., Nakano, S., Nagatoishi, S., Tsumoto, K., Takeuchi, Y., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-26638-5 · Cited by 39
Structure and Function of Bone Marrow Adipocytes
de Paula, F. J. A., & Rosen, C. J. (2017) · Comprehensive physiology · doi:10.1002/cphy.c170010 · Cited by 43
Li, H., Zhu, H., Ge, T., Wang, Z., & Zhang, C. (2021) · Stem Cell Reviews and Reports · doi:10.1007/s12015-021-10139-5 · Cited by 37
Gowd, V., Xiao, J., Wang, M., Chen, F., & Cheng, K. (2021) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.202100252 · Cited by 42
A Novel Nomogram for Predicting Gestational Diabetes Mellitus During Early Pregnancy
Kang, M., Zhang, H., Zhang, J., Huang, K., Zhao, J., Hu, J., Lu, C., Shao, J., Weng, J., Yang, Y., et al. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.779210 · Cited by 36
“Owing to the similar pathology with type 2 diabetes mellitus, GDM is regarded as the early stage of T2DM (8).”
BackgroundInsulin Resistance in Mitochondrial Diabetes
Takano, C., Ogawa, E., & Hayakawa, S. (2023) · Biomolecules · doi:10.3390/biom13010126 · Cited by 42
“IR is a pathologic condition in which insulin-dependent cells, such as skeletal muscle and adipocytes, fail to respond properly to normal circulatory levels of insulin [1,2].”
BackgroundNew insights into anti-diabetes effects and molecular mechanisms of dietary saponins
Zhou, Y., & Xu, B. (2022) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2022.2101425 · Cited by 41
“The phosphorylated Akt participates in insulin metabolism in two aspects: the inactivation of glycogen synthase kinase 3 beta (GSK3β) and the translocation of GLUT-4 vehicles to the cell membrane, which in turn triggers the glucose uptake and GS-mediated glycogen synthesis (Samuel and Shulman 2016).”
BackgroundPhloretin: a comprehensive review of its potential against diabetes and associated complications
Shelke, V., Kale, A., Kulkarni, Y. A., & Gaikwad, A. B. (2024) · Journal of Pharmacy and Pharmacology · doi:10.1093/jpp/rgae010 · Cited by 35
Polycystic Ovary Syndrome, Insulin Resistance, and Cardiovascular Disease
Dubey, P., Reddy, S., Sharma, K., Johnson, S., Hardy, G., & Dwivedi, A. K. (2024) · Current Cardiology Reports · doi:10.1007/s11886-024-02050-5 · Cited by 51
“PCOS-related hepatic IR is usually only present in obese women, leading to a deficiency in insulin-stimulated liver glycogen synthesis and insulin-mediated inhibition of hepatic glucose production [94].”
Exercise as a tool to mitigate metabolic disease
Esteves, J. V. D. C., & Stanford, K. I. (2024) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00144.2024 · Cited by 41
Li, D., Long, W., Huang, R., Chen, Y., & Xia, M. (2018) · Obesity · doi:10.1002/oby.22130 · Cited by 34
“Many studies have demonstrated that ectopic lipid in the liver is specifically associated with insulin resistance, even when controlling for hepatic insulin resistance because of obesity and visceral adiposity (35-37).”
BackgroundAdriano, L. S., Dionísio, A. P., de Abreu, F. A. P., Carioca, A. A. F., Zocolo, G. J., Wurlitzer, N. J., PINTO, C. D. O., de Oliveira, A. C., & Sampaio, H. A. D. C. (2019) · Food Research International · doi:10.1016/j.foodres.2019.108682 · Cited by 39
Ugwoke, C. K., Cvetko, E., & Umek, N. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23020847 · Cited by 42
“Decreased expression of IRS-1 and 2 and decreased phosphorylation of Akt and eNOS are key hallmarks of vascular insulin resistance [37,48].”
BackgroundNonalcoholic fatty liver disease and insulin resistance in children
Song, K., Kim, H.-S., & Chae, H. W. (2023) · Korean Journal of Pediatrics · doi:10.3345/cep.2022.01312 · Cited by 41
Mariné-Casadó, R., Domenech-Coca, C., Bas-Prior, J. M. D., Bladé, C., Arola, L., & Caimari, A. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.00416 · Cited by 44
“…accumulation of hepatic lipids— mainly diglycerides—contributes to altered insulin signaling that could trigger a rise in circulating glucose levels (Samuel and Shulman, 2016), it is tempting to speculate that the increased glycerophosphocholine and diglycerides observed in L18 rats could account…”
BackgroundJones, A. K., Brown, L. D., Rozance, P. J., Serkova, N. J., Hay, W. W., Friedman, J. E., & Wesolowski, S. R. (2019) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00359.2018 · Cited by 37
“Intrauterine insults, including intrauterine growth restriction (IUGR), can increase the life-long risk for metabolic diseases, including type 2 diabetes (T2DM) (3, 19, 32, 35).”
BackgroundInfluentialThe role of spexin in energy metabolism
Sun, X., Yu, Z., Xu, Y., Pu, S., & Gao, X. (2023) · Peptides · doi:10.1016/j.peptides.2023.170991 · Cited by 35
Blocking iNOS and endoplasmic reticulum stress synergistically improves insulin resistance in mice
Zanotto, T. M., Quaresma, P. G. F., Guadagnini, D., Weissmann, L., Santos, A. C., Vecina, J. F., Calisto, K. L., Santos, A., Prada, P. O., & Saad, M. J. A. (2016) · Molecular Metabolism · doi:10.1016/j.molmet.2016.12.005 · Cited by 32
Muñoz, V. R., Gaspar, R. C., Crisol, B., Formigari, G. P., Sant’Ana, M. R., Botezelli, J. D., Gaspar, R. S., da Silva, A. S. R., Cintra, D. E., de Moura, L. P., et al. (2017) · The Journal of Physiological Sciences · doi:10.1007/s12576-017-0559-3 · Cited by 34
“22), indicating PCB protein and FFA serum levels have a major contribution in altering fasting glucose levels [35].”
BackgroundSharma, N., Key, C.-C. C., Civelek, M., Wabitsch, M., Comeau, M. E., Langefeld, C. D., Parks, J. S., & Das, S. K. (2019) · Diabetes · doi:10.2337/db18-1229 · Cited by 34
“The failure of adipocytes to sequester excess fuel during nutritional abundance results in ectopic fat accumulation and is proposed as a trigger for systemic IR (1,14,15).”
BackgroundDHT causes liver steatosis via transcriptional regulation of SCAP in normal weight female mice
Seidu, T. A., McWhorter, P., Myer, J., Alamgir, R., Eregha, N., Bogle, D., Lofton, T., ECELBARGER, C. A., & Andrisse, S. (2021) · Journal of Endocrinology · doi:10.1530/joe-21-0040 · Cited by 35
Novel insights into the pathological mechanisms of metabolic related dyslipidemia
Su, X., Cheng, Y., Zhang, G., & Wang, B. (2021) · Molecular Biology Reports · doi:10.1007/s11033-021-06529-0 · Cited by 38
Metadata
- Authors
- Samuel, V. T., & Shulman, G. I.
- Affiliations
- Veterans Health Administration (US)
- Howard Hughes Medical Institute (US)
- Venue
- Journal of Clinical Investigation
- Published
- 2016-01-04
- Volume
- 126
- Issue
- 1
- Pages
- 12-22
- ISSN
- 0021-9738 (ISSN-L)
- 1558-8238
- PMC
- PMC4701542
- OpenAlex
- W2230222215
- Cited by
- 1,484
- References
- 131
- Citations by year
- 2026: 192 · 2025: 162 · 2024: 152 · 2023: 150 · 2022: 150 · 2021: 143 · 2020: 134 · 2019: 136 · 2018: 114 · 2017: 99 · 2016: 51
- FWCI
- 18.06
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- U.S. Department of Veterans Affairs (I01 BX000901)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK-49230, R01DK049230, DK40936, DK 45735, R01DK040936, U24DK059635, R24DK085638, DK059635, DK-085638, P30DK045735)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- insulin resistance, type 2 diabetes, ectopic fat deposition, hepatic insulin signaling, skeletal muscle glucose uptake, hepatic gluconeogenesis, hepatic de novo lipogenesis, adipose tissue lipolysis, hepatic triglyceride synthesis, fatty acid esterification, hyperlipidemia, hyperglycemia, pyruvate carboxylase, acetyl-CoA, substrate flux, inflammation, energy surplus
- MeSH terms
- Adipose Tissue, Animals, Glucose, Humans, Insulin Resistance, Liver, Triglycerides, Signal Transduction, Muscle, Skeletal, Lipid Metabolism
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.